ConductScience.org, home

Paper39201338

Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.

Tonon G and 3 others. Int J Mol Sci, 2024. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads. Papers, record 39201338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201338

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.34, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tonon GGiovanni
2Rizzolio FFlaviohttps://orcid.org/0000-0002-3400-4363
3Visentin FFabiano
4Scattolin TThomashttps://orcid.org/0000-0001-7345-9670

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
ImmunoconjugatesMajor topic
Humans
Antineoplastic Agents
Animals
Antibodies, Monoclonal

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IG23566AIRCPubMed

Source PubMed

Download CSV of grants

References203

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122881720Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy.Bioconjug Chem2012https://conductscience.org/library/papers/22881720PubMed
231011424Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma.Biomark Res2019https://conductscience.org/library/papers/31011424PubMed
338555326Transforming toxins into treatments: the revolutionary role of α-amanitin in cancer therapy.Arch Toxicol2024https://conductscience.org/library/papers/38555326PubMed
435285835Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis.Dalton Trans2022https://conductscience.org/library/papers/35285835PubMed
532402935Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.Eur J Med Chem2020https://conductscience.org/library/papers/32402935PubMed
632698317Monoclonal Antibodies in Cancer Therapy.Antibodies (Basel)2020https://conductscience.org/library/papers/32698317PubMed
728613309A simple synthetic entryway into palladium cross-coupling catalysis.Chem Commun (Camb)2017https://conductscience.org/library/papers/28613309PubMed
821457108The development of pyrrolobenzodiazepines as antitumour agents.Expert Opin Investig Drugs2011https://conductscience.org/library/papers/21457108PubMed
910565792Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.J Nucl Med1999https://conductscience.org/library/papers/10565792PubMed
1033926914First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors.Clin Cancer Res2021https://conductscience.org/library/papers/33926914PubMed
1110755652Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb.Nucl Med Biol2000https://conductscience.org/library/papers/10755652PubMed
1233845034Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.Lancet Oncol2021https://conductscience.org/library/papers/33845034PubMed
1330095185Bioconjugation with Maleimides: A Useful Tool for Chemical Biology.Chemistry2019https://conductscience.org/library/papers/30095185PubMed
148324745Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.Cancer Res1993https://conductscience.org/library/papers/8324745PubMed
1530478951Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes.J Cell Physiol2019https://conductscience.org/library/papers/30478951PubMed
1635770072Heptadentate chelates for 89Zr-radiolabelling of monoclonal antibodies.Inorg Chem Front2022https://conductscience.org/library/papers/35770072PubMed
177850803Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.Cancer Res1995https://conductscience.org/library/papers/7850803PubMed
1837146495Analytical methods for amatoxins: A comprehensive review.J Pharm Biomed Anal2023https://conductscience.org/library/papers/37146495PubMed
1933461955Efficacy and Safety of Inotuzumab Ozogamicin (CMC-544) for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.Clin Lymphoma Myeloma Leuk2021https://conductscience.org/library/papers/33461955PubMed
202353935Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.Biochem Pharmacol1990https://conductscience.org/library/papers/2353935PubMed

See all 203 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42633296Metal coordination at biological interfaces: Mechanisms, therapeutics, and translation.Mater Today Bio2026https://conductscience.org/library/papers/42633296PubMed
42389487Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways.J Pharm Anal2026https://conductscience.org/library/papers/42389487PubMed
42168552Metabolotheranostics of pancreatic cancer by targeting choline, glutamine, and glucose transporters with photoimmunotherapy.Npj Imaging2026https://conductscience.org/library/papers/42168552PubMed
42099878Antibody-drug conjugates in cancer treatment: from molecular design to clinical implementation.Lancet Reg Health Eur2026https://conductscience.org/library/papers/42099878PubMed
42079870Antibody-drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges.Front Chem2026https://conductscience.org/library/papers/42079870PubMed
41789080Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer.Front Immunol2026https://conductscience.org/library/papers/41789080PubMed
41311216Antibody-oligonucleotide conjugates for spatial proteomics: principles, applications, and challenges.Acta Biochim Biophys Sin (Shanghai)2025https://conductscience.org/library/papers/41311216PubMed
41304752Camptothecin in Cancer Therapy: Current Challenges and Emerging Strategies with Nanoemulsions.Pharmaceutics2025https://conductscience.org/library/papers/41304752PubMed
40827507Evolving bioanalytical strategies in the wake of pioneering biotherapeutics.Bioanalysis2025https://conductscience.org/library/papers/40827507PubMed
40129921Antibody conjugates in neuroblastoma: a step forward in precision medicine.Front Oncol2025https://conductscience.org/library/papers/40129921PubMed
40075649Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives.Cancers (Basel)2025https://conductscience.org/library/papers/40075649PubMed
39769122Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?Int J Mol Sci2024https://conductscience.org/library/papers/39769122PubMed
39582282Assessing the expression of Nectin-4 in solid tumors by immunohistochemistry - what do we know?Histol Histopathol2025https://conductscience.org/library/papers/39582282PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201338

GET https://conductscience.org/api/papers/v1/39201338/references?page=2